<p>Study level subgroup analysis of sources of heterogeneity regarding the proportion of stage I cancers in CT lung cancer screening studies.</p
<p>Subgroup analyses by study design, types of infection, outcome measures and study location.</p
<p>Kaplan-Meier analysis for cancer-specific survival stratified by subgroups of gastric cancer pati...
<p>Subgroup analyses of TC, HDL-C, and LDL-C stratified by previously defined study characteristics....
<p>Individual patient data subgroup analysis of sources of heterogeneity regarding the proportion of...
<p>(A) Squamous Cell Carcinoma (SCC) subgroup analysis, based on the random effects model. (B) Adeno...
<p><b>Abbreviations:</b> No. of datasets, Number of datasets (papers); MDS, Myelodysplastic Syndrome...
Summary of heterogeneity and subgroup analysis based on study year, sample size and study regions.</...
<p>Subgroup analysis of lung cancer for folate intake versus the lowest intake.</p
<p>Subgroup analysis for high versus low PUFA intake for lung cancer (A); Subgroup analysis for per ...
<p>Subgroup analysis of the prevalence of ASB by quality of included studies, geographic regions, an...
<p>Subgroup analysis of the relationship between age and lymph node involvement by tumor size.</p
<p>Assessment of clinical heterogeneity: subgroup analysis for order of treatment.</p
<p>Subgroup analyses for association between HCC surveillance and early detection, curative treatmen...
Proportion of study participants disaggregated by the type of cancers and the country in which they ...
<p>(A) Subgroup analysis of HRs of OS by factor of sample size. (B) Subgroup analysis of HRs of OS b...
<p>Subgroup analyses by study design, types of infection, outcome measures and study location.</p
<p>Kaplan-Meier analysis for cancer-specific survival stratified by subgroups of gastric cancer pati...
<p>Subgroup analyses of TC, HDL-C, and LDL-C stratified by previously defined study characteristics....
<p>Individual patient data subgroup analysis of sources of heterogeneity regarding the proportion of...
<p>(A) Squamous Cell Carcinoma (SCC) subgroup analysis, based on the random effects model. (B) Adeno...
<p><b>Abbreviations:</b> No. of datasets, Number of datasets (papers); MDS, Myelodysplastic Syndrome...
Summary of heterogeneity and subgroup analysis based on study year, sample size and study regions.</...
<p>Subgroup analysis of lung cancer for folate intake versus the lowest intake.</p
<p>Subgroup analysis for high versus low PUFA intake for lung cancer (A); Subgroup analysis for per ...
<p>Subgroup analysis of the prevalence of ASB by quality of included studies, geographic regions, an...
<p>Subgroup analysis of the relationship between age and lymph node involvement by tumor size.</p
<p>Assessment of clinical heterogeneity: subgroup analysis for order of treatment.</p
<p>Subgroup analyses for association between HCC surveillance and early detection, curative treatmen...
Proportion of study participants disaggregated by the type of cancers and the country in which they ...
<p>(A) Subgroup analysis of HRs of OS by factor of sample size. (B) Subgroup analysis of HRs of OS b...
<p>Subgroup analyses by study design, types of infection, outcome measures and study location.</p
<p>Kaplan-Meier analysis for cancer-specific survival stratified by subgroups of gastric cancer pati...
<p>Subgroup analyses of TC, HDL-C, and LDL-C stratified by previously defined study characteristics....